SUPERFICIAL FEMORAL ARTERY DISEASE
Clinical trials for SUPERFICIAL FEMORAL ARTERY DISEASE explained in plain language.
Never miss a new study
Get alerted when new SUPERFICIAL FEMORAL ARTERY DISEASE trials appear
Sign up with your email to follow new studies for SUPERFICIAL FEMORAL ARTERY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stent aims to keep leg arteries open longer
Disease control CompletedThis trial is testing a new stent called Renzan to treat blockages in the leg arteries (superficial femoral or popliteal arteries). The study includes about 135 people with moderate to severe peripheral artery disease. Researchers want to see if the stent is safe and effective at…
Matched conditions: SUPERFICIAL FEMORAL ARTERY DISEASE
Phase: NA • Sponsor: Terumo Europe N.V. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New stent helps people with leg artery disease walk better and feel better
Disease control CompletedThis study looked at how well the ELUVIA drug-coated stent works in real-world patients with blocked arteries in the thigh or knee area. A total of 291 adults received the stent and were followed for two years. The main goal was to see if their quality of life and walking ability…
Matched conditions: SUPERFICIAL FEMORAL ARTERY DISEASE
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC